The effectiveness of high-dose versus low-dose corticosteroid therapy in children with acute respiratory distress syndrome: a randomized controlled study

Abstract Background Acute respiratory distress syndrome (ARDS) is an evident cause of morbidity and mortality in children admitted to pediatric intensive care units (PICUs). However, corticosteroid administration in ARDS remains controversial. This study evaluates the effects of high-dose versus low-dose methylprednisolone and the impact of early versus late corticosteroid initiation on clinical outcomes in pediatric ARDS. Methods This prospective, open-label, randomized study was conducted in the Ain Shams University Children’s Hospital PICU from October 2022 to June 2023. Forty children diagnosed with ARDS, per the 2012 Berlin definition, were randomized into two groups: high-dose methylprednisolone (30 mg/kg/day for 3 days) and low-dose methylprednisolone (2 mg/kg/day for 3 days). Clinical, laboratory, radiological, and biomarker assessments were performed before and 3 days after initiating therapy. Results There were no significant differences in clinical outcomes or length of PICU stay between both groups. Changes in alveolar procollagen peptide I ( p -value = 0.883), lung compliance ( p -value = 0.547), chest ultrasound BLUE score ( p -value = 0.192), and arterial blood gas parameters showed no significant differences between the groups. Change in lung ultrasound BLUE score (decrease more than 1) and lung compliance (increase more than 0.4) showed predictive values for outcome prognosis ( p -value < 0.001). Early initiation of corticosteroids was associated with significantly improved outcomes, with 100% survival, compared to late initiation (after 3 days), which was associated with 100% mortality ( p -value < 0.001). Conclusions Early corticosteroid initiation within 72 h of ARDS diagnosis significantly improves outcomes, irrespective of dose. Both high-dose and low-dose regimens demonstrated similar effects on clinical, biomarker, and radiological outcomes.

Authors

Institutions

Publication Details

Journal
Egyptian Pediatric Association Gazette
Published
2025-09-15
DOI
https://doi.org/10.1186/s43054-025-00429-9
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effectiveness of high-dose versus low-dose corticosteroid therapy in children with acute respiratory distress syndrome: a randomized controlled study

Hanan Ibrahim, Hossam Moussa Sakr, Ahmed R. Rezk, Manal M Abd Al Aziz et al.
Egyptian Pediatric Association Gazette
Respiratory Support and Mechanisms
article

The effectiveness of high-dose versus low-dose corticosteroid therapy in children with acute respiratory distress syndrome: a randomized controlled study

Hanan Ibrahim, Hossam Moussa Sakr, Ahmed R. Rezk, Manal M Abd Al Aziz, Habeba M Abdelaty Oun
article en

Abstract

Abstract Background Acute respiratory distress syndrome (ARDS) is an evident cause of morbidity and mortality in children admitted to pediatric intensive care units (PICUs). However, corticosteroid administration in ARDS remains controversial. This study evaluates the effects of high-dose versus low-dose methylprednisolone and the impact of early versus late corticosteroid initiation on clinical outcomes in pediatric ARDS. Methods This prospective, open-label, randomized study was conducted in the Ain Shams University Children’s Hospital PICU from October 2022 to June 2023. Forty children diagnosed with ARDS, per the 2012 Berlin definition, were randomized into two groups: high-dose methylprednisolone (30 mg/kg/day for 3 days) and low-dose methylprednisolone (2 mg/kg/day for 3 days). Clinical, laboratory, radiological, and biomarker assessments were performed before and 3 days after initiating therapy. Results There were no significant differences in clinical outcomes or length of PICU stay between both groups. Changes in alveolar procollagen peptide I ( p -value = 0.883), lung compliance ( p -value = 0.547), chest ultrasound BLUE score ( p -value = 0.192), and arterial blood gas parameters showed no significant differences between the groups. Change in lung ultrasound BLUE score (decrease more than 1) and lung compliance (increase more than 0.4) showed predictive values for outcome prognosis ( p -value < 0.001). Early initiation of corticosteroids was associated with significantly improved outcomes, with 100% survival, compared to late initiation (after 3 days), which was associated with 100% mortality ( p -value < 0.001). Conclusions Early corticosteroid initiation within 72 h of ARDS diagnosis significantly improves outcomes, irrespective of dose. Both high-dose and low-dose regimens demonstrated similar effects on clinical, biomarker, and radiological outcomes.

Egyptian Pediatric Association GazetteVol. 73(1)
Ain Shams University (EG), Ministry of Health and Population (EG)
Openalex Percentile: Top 64%
Respiratory Support and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.